| Literature DB >> 35335956 |
Anasztázia Hetényi1, Enikő Szabó2, Norbert Imre1, Kaushik Nath Bhaumik1, Attila Tököli1, Tamás Füzesi1, Réka Hollandi3, Peter Horvath3, Ágnes Czibula2, Éva Monostori2, Mária A Deli4, Tamás A Martinek1.
Abstract
Cell delivery of therapeutic macromolecules and nanoparticles is a critical drug development challenge. Translocation through lipid raft-mediated endocytic mechanisms is being sought, as it can avoid rapid lysosomal degradation. Here, we present a set of short α/β-peptide tags with high affinity to the lipid raft-associated ganglioside GM1. These sequences induce effective internalization of the attached immunoglobulin cargo. The structural requirements of the GM1-peptide interaction are presented, and the importance of the membrane components are shown. The results contribute to the development of a receptor-based cell delivery platform.Entities:
Keywords: alpha-beta peptide; cell delivery; endocytosis; glycan recognition; immunoglobulin
Year: 2022 PMID: 35335956 PMCID: PMC8953856 DOI: 10.3390/pharmaceutics14030580
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.321
Binding affinities (KD [nM]) of the WYKYW analogues to ganglioside GM1. The binding stoichiometry (n1) was 0.5 in all cases. Superscripts indicate the corresponding peptide termini.
| NW | Y | K | Y | WC | |
|---|---|---|---|---|---|
| original | 23.8 | ||||
| Ala-scan | n.f. [a] | 5755 | 10,467 | 1694 | 1060 |
| 881 | 892 | 4523 | 3243 | 3926 | |
| β-scan | 4.3 | 60 | 332 | 40 | 86 |
[a] not fittable.
Figure 1The blue-shift of the tryptophan fluorescence emission in interaction with GM1:DPC micelles. Emission spectra obtained for peptide WYKYW alone (black, 2.5 µM), WYKYW + DPC (DPC 250 µM, dash-dotted), and WYKYW + GM1:DPC (+GM1:DPC 50:250 µM, dotted).
Figure 2CD spectra measured for peptide WYKYW alone (black, 200 µM) and after adding 100:500 µM GM1:DPC bicelles (dotted).
Figure 3Pharmacophore hypothesis generated from the SAR and Trp-fluorescence data.
Figure 4Schematic representation of the bottom-up designed modular carrier–hub–antibody cargo–secondary antibody–fluorescent-dye construct.
Figure 5Delivery of the IgG cargo into HeLa cells, using the carrier WYKYW and its α,β-peptidic derivatives. The schematic representation of the carrier–cargo complex is given in Figure 4. Images are tagged by the carrier sequence measured (β denotes the corresponding β3-amino acid). Alexa Fluor 647-conjugated secondary antibody is indicated in magenta; green staining defines cell membranes (WGA-FITC). Nuclei are indicated in cyan. The carrier–cargo complexes we applied at a concentration of 80 nM, and cells were incubated for 1 h. In the control measurement, cells were treated with IgG complex without the ganglioside-binding carrier peptides attached.
Figure 6Artificial intelligence-aided quantitative analysis of the live CLSM images. HeLa cells were incubated for 1 or 4 h with the carrier–cargo complexes at 80 nM. At least 150 representative cells were then analyzed at each setup. The graph shows mean fluorescence intensity values ± standard error of the mean (SEM). Statistical analysis was performed using one-way analysis of variance (ANOVA) with Dunnett’s multiple comparison test, where each sample was compared to the control sample of the matching time point. *** p < 0.001.